Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compliance Study Comparing DuoTrav to TRAVATAN Plus Timolol
NCT00465803Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2007
- Primary completion
- Jan 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of travoprost and timolol in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Patient compliance at 12 months. Started Mar 2007; status: completed.
02
Drugs
travoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00465803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465803.